NASDAQ:ONCT
Delisted

Oncternal Therapeutics Stock News

etoro logo Buy ONCT
*Your capital is at risk
$0.527
+0 (+0%)
At Close: Feb 28, 2025
Oncternal Therapeutics, Inc. (NASDAQ:ONCT ) Q1 2023 Results Conference Call May 4, 2023 5:00 PM ET Company Participants Salim Yazji - CMO James Breitmeyer - President, CEO Richard Vincent - CFO Confer
Oncternal Therapeutics (ONCT) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.20 per share a year ago.
Penny stocks under $1 to watch this week. The post Penny Stocks To Buy?
Penny stocks to watch trading for pennies this week. The post Penny Stocks To Buy?
Oncternal (ONCT) closes the development program for zilovertamab to extend its cash runway into 2025. Shares are down on the same.
Oncternal Therapeutics (NASDAQ: ONCT ) stock is falling hard on Tuesday after the company decided to end two clinical trials. Oncternal Therapeutics has announced that it's closing its Zilovertamab Ph
Oncternal Therapeutics, Inc. (NASDAQ:ONCT ) Q4 2022 Earnings Conference Call March 9, 2023 5:00 PM ET Company Participants James Breitmeyer - President and CEO Richard Vincent - CFO Salim Yazji - Chie
As ONCT's MCL Phase 2 study continues to mature, the data also continues to improve.  In fact, the data now looks outstanding. Thus, I believe that the chances of success in the newly initiated Phase
Oncternal Therapeutics, Inc. (NASDAQ:ONCT ) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Rich Vincent - Chief Financial Officer Dr. James Breitmeyer - President an
Oncternal Therapeutics (ONCT) delivered earnings and revenue surprises of 12.50% and 11.78%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the st
SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today annou
SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today anno
Today, we are circling back on Oncternal Therapeutics, Inc. for the first time since last October. Despite advancing its pipeline and strong analyst support, the stock currently sells for less than th
Oncternal Therapeutics, Inc. (NASDAQ:ONCT ) Q2 2022 Earnings Conference Call August 9, 2022 5:00 PM ET Company Participants Richard Vincent - Chief Financial Officer Dr. James Breitmeyer - President a

How World Events Impact Penny Stocks in 2022

11:30am, Saturday, 06'th Aug 2022
How to take advantage of world events for trading penny stocks The post How World Events Impact Penny Stocks in 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE